The Rational Use of Antibiotics

Slides:



Advertisements
Similar presentations
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Advertisements

BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.
Principles Of Antibiotics use Abdulrahman M. Al Mazrou, FRCPC Professor of Pediatrics,KSU Consultant, Pediatric Infectious diseases,KFMC Rajab-1431.
Do Health Care Regulation and Physician-Industry Interaction Influence Antibiotic Resistance Rates? The Example of Antimicrobial Prescribing and Dispensing.
Drug Utilization Review (DUR)
Judicious Antibiotic Use in Developing Countries Global Missions Health Conference Louisville, KY Nov. 9, 2012 Ron Herman, Ph.D.
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
Lesson 3 Good Production Practice #3 Use Antibiotics Responsibly.
Should we change the recommendations related to antibiotic drug dosage/drug duration? Workshop on Economic Epidemiology Makerere University August, 2009.
Michael R. Jacobs, MD, PhD Professor of Pathology and Medicine Case Western Reserve University Director of Clinical Microbiology University Hospitals of.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.
Chapter 10: Restricting antibiotic use and optimizing dosing.
Pharmacodynamics of Antibiotics
CHEMOTHERAPY  Antimicrobial chemotherapy  Antiviral chemotherapy  Antiparasitic Drugs  Cancer Chemotherapy.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.
Introduction to Antibiotics Prof. Azza ELMedany Pharmacology Department.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Rational use of antibiotics in child infection
PRESENTER: HALIMATUL NADIA M HASHIM SUPERVISOR: DR NIK AZMAN NIK ADIB.
Infection Control Clinical Pharmacy and Patient Safety
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
Introduction to Antimicrobials. General Terms Chemotherapy Antibiotic – substance produced by a microbe that may harm another microbes Antimicrobial –
CHEMOTHERAPY  Antimicrobial chemotherapy  Antiviral chemotherapy  Antiparasitic Drugs  Cancer Chemotherapy.
PRINCIPLES OF PROPHYLAXIS OF INFECTION 1)Procedure should have significant risk of infection 2)Choose correct antibiotic 3)Antibiotic plasma level must.
Antibiotics!.
8th ISAP Symposium Can PK/PD be used in everyday clinical practice? Francesco Scaglione Department of Pharmacology, Toxicology and Chemotherapy, University.
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Antibiotics and the Resident
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Mohammad Alhumayyd Pharmacology Department Tel
Ten Years After: Where is ISAP?
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Introduction to Antibiotics Prof. Mohammad Alhumayyd Pharmacology Department.
Pharmacodynamics of Antifungals
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Antibiotic Resistance Emerging antibiotic resistance is a major health concern. 2 million people in the U.S. infected with antibiotic resistant bacteria.
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS (part II)
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Basic Principles of Antimicrobial Therapy Chapter 79.
Introduction to Antibiotics 1 st yr( Respiratory block) Prof. Azza Elmedany.
PK/PD: TOWARDS DEFINITIVE CRITERIA PK/PD in clinical Practice: new level of PK/PD Francesco Scaglione Department of Pharmacology, Toxicology and Chemotherapy,
Nosocomial infection Hospital acquired infections.
Pharmacodynamics of Antimicrobials William A. Craig, M.D. University of Wisconsin-Madison.
Nosocomial infection Hospital acquired infections.
Antibiotic utilization in general medical units in a tertiary care institution Fernando GVMC, Ratnasekera IU, Perera MSD, Wanigatunge CA.
Risk Factors for Linezolid-Associated Thrombocytopenia in Adult Patients Cristina Gervasoni Ospedale Luigi Sacco, Milano.
Antimicrobial Stewardship
Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.
Antibiotics: handle with care!
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
Use of antibiotics.
Hospital acquired infections
Clinical pharmacy Antimicrobial prophylaxis Lec:2
Stevce Acevski PhD Alkaloid AD ISPOR Macedonia
Principles of Antimicrobial use and Drug Resistance Omilabu S.A, Ph.D Department of Medical Microbiology and Parasitology, CMUL. 16 th January 2015.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Hospital Antibiotic Stewardship Programs
Antibiotic Resistance Emerging antibiotic resistance is a major health concern. 2 million people in the U.S. infected with antibiotic resistant bacteria.
Presentation Title 36pt Arial Bold
بنام خداوند جان و خرد بنام خداوند جان و خرد.
Pharmacodynamic indices in targeting therapy of critical infections
M.R. Jacobs  Clinical Microbiology and Infection 
ANTIBIOTIC STEWARDSHIP PROGRAM
Molecular Testing and Therapeutic Management in the Treatment of Infectious Disease Leveraging the latest science and a team-based approach to improve.
Presentation transcript:

The Rational Use of Antibiotics Victor Lim International Medical University Kuala Lumpur, Malaysia

Antibiotics One of the most commonly used group of drugs In USA 23 million kg used annually; 50% for medical reasons May account for up to 50% of a hospital’s drug expenditure Studies worldwide has shown a high incidence of inappropriate use

Reasons for appropriate use Avoid adverse effects on the patient Avoid emergence of antibiotic resistance - ecological or societal aspect of antibiotics Avoid unnecessary increases in the cost of health care

Ecological/Societal Aspect Antibiotics differ from other classes of drugs The way in which a physician and other professionals use an antibiotic can affect the response of future patients Responsibility to society Antibiotic resistance can spread from bacteria to bacteria patient to patient animals to patients

Prescribing an antibiotic Is an antibiotic necessary ? What is the most appropriate antibiotic ? What dose, frequency, route and duration ? Is the treatment effective ?

Is an antibiotic necessary ? Useful only for the treatment of bacterial infections Not all fevers are due to infection Not all infections are due to bacteria There is no evidence that antibiotics will prevent secondary bacterial infection in patients with viral infection

Arroll and Kenealy, Antibiotics for the common cold Arroll and Kenealy, Antibiotics for the common cold. Cochrane Database of Systematic Reviews. Issue 4, 2003 Meta-analysis of 9 randomised placebo controlled trials involving 2249 patients Conclusions: There is not enough evidence of important benefits from the treatment of upper respiratory tract infections with antibiotics and there is a significant increase in adverse effects associated with antibiotic use.

Is an antibiotic necessary ? Not all bacterial infections require antibiotics Consider other options : antiseptics surgery

Choice of an antibiotic Aetiological agent Patient factors Antibiotic factors

The aetiological agent Clinical diagnosis clinical acumen the most likely site/source of infection the most likely pathogens empirical therapy universal data local data

Importance of local antibiotic resistance data Resistance patterns vary From country to country From hospital to hospital in the same country From unit to unit in the same hospital Regional/Country data useful only for looking at trends NOT guide empirical therapy

The aetiological agent Laboratory diagnosis interpretation of the report what is isolated is not necessarily the pathogen was the specimen properly collected ? is it a contaminant or coloniser ? sensitivity reports are at best a guide

Patient factors Age Physiological functions Genetic factors Pregnancy Site and severity of infection Allergy

Antibiotic factors Pharmacokinetic/pharmacodynamic (PK/PD) profile absorption excretion tissue levels peak levels, AUC, Time above MIC Toxicity and other adverse effects Drug-drug interactions Cost

PK/PD Parameters Increasing knowledge on the association between PK/PD parameters on clinical efficacy and preventing emergence of resistance Enabled doctors to optimise dosage regimens Led to redefinition of interpretative breakpoints in sensitivity testing

Antibiotic concentration (ug/ml) Important PK/PD Parameters Important PK/PD Parameters Time above MIC : Proportion of the dosing interval when the drug concentration exceeds the MIC 8 6 Drug A Drug A 4 Drug B Drug B Antibiotic concentration (ug/ml) 2 B B A Time Time above MIC

Area under the curve over MIC Antibiotic concentration Important PK/PD Parameters Area under the curve over MIC AUC/MIC is the ratio of the AUC to MIC Peak/MIC is the ratio of the peak concentration to MIC PEAK Antibiotic concentration MIC Time

PK/PD and Antimicrobial Efficacy 2 main patterns of bacterial killing Concentration dependent Aminoglycosides, quinolones, macrolides, azalides, clindamycin, tetracyclines, glycopeptides, oxazolidinones Correlated with AUC/MIC , Peak/MIC Time dependent with no persistent effect Betalactams Correlated with Time above MIC (T>MIC) Craig, 4th ISAAR, Seoul 2003

Goal of therapy and relevant PK/PD Parameter Goal of therapy based on PK/PD Pattern of Activity Antimicrobials Goal of therapy and relevant PK/PD Parameter Concentration dependent killing AMGs, Quinolones, Daptomycin, ketolides, Macrolides, azithro-mycin, clindamycin, streptogramines,tetracyclines, glycopeptides, oxazolidinones Maximise concentrations; AUC/MIC, peak/MIC Use high doses; daily dosing for some agents Time dependent killing with no persistent effects Betalactams Maximise duration of exposure; T>MIC Use more frequent dosing; longer infusion times including continuous infusion

Cost of antibiotic Not just the unit cost of the antibiotic Materials for administration of drug Labour costs Expected duration of stay in hospital Cost of monitoring levels Expected compliance

Choice of regimen Oral vs parenteral Traditional view “serious = parenteral” previous lack of broad spectrum oral antibiotics with reliable bioavailability Improved oral agents higher and more persistent serum and tissue levels for certain infections as good as parenteral

Advantages of oral treatment Eliminates risks of complications associated with intravascular lines Shorter duration of hospital stay Savings in nursing time Savings in overall costs

Duration of treatment In most instances the optimum duration is unknown Duration varies from a single dose to many months depending on the infection Shorter durations, higher doses For certain infections a minimum duration is recommended

Recommended minimum durations of treatment

Monitoring efficacy Early review of response Routine early review Increasing or decreasing the level of treatment depending on response change route change dose change spectrum of antibacterial activity stopping antibiotic

Antimicrobial-Resistant Pathogen Antimicrobial Resistance Campaign to Prevent Antimicrobial Resistance in Healthcare Settings Antimicrobial Resistance: Key Prevention Strategies Susceptible Pathogen Antimicrobial-Resistant Pathogen Pathogen Infection Prevent Transmission Prevent Infection Antimicrobial Use Antimicrobial Resistance Effective Diagnosis & Treatment Optimize Use

12 Steps to Prevent Antimicrobial Resistance Campaign to Prevent Antimicrobial Resistance in Healthcare Settings 12 Steps to Prevent Antimicrobial Resistance 12 Break the chain 11 Isolate the pathogen 10 Stop treatment when cured 9 Know when to say “no” to vanco 8 Treat infection, not colonization 7 Treat infection, not contamination 6 Use local data 5 Practice antimicrobial control 4 Access the experts 3 Target the pathogen 2 Get the catheters out 1 Vaccinate Prevent Transmission Use Antimicrobials Wisely Diagnose & Treat Effectively Prevent Infections

Conclusions Antibiotic resistance is a major problem world-wide Resistance is inevitable with use No new class of antibiotic introduced over the last two decades Appropriate use is the only way of prolonging the useful life of an antibiotic